Prevention of Ph+ acute lymphoblastic leukemia by nanoparticulate delivery of a DNA vaccine in syngeneic mice

被引：2

作者：

Koechling, Joachim ^{[1
]}

Rott, Yvonne ^{[1
]}

Anidt, Stefanie ^{[1
]}

Green, Jordan ^{[2
]}

Anderson, Daniel ^{[3
]}

Langer, Robert

Stripecke, Renata ^{[4
]}

Wittig, Burghardt ^{[5
,6
]}

Schmidt, Manuel ^{[5
]}

机构：

[1] Univ Lubeck, Dept Pediat, Univ Klinikum Schleswig Holstein, Lubeck, Germany

[2] MIT, Div Biol Engn, Cambridge, MA 02139 USA

[3] MIT, Ctr Canc Res, Cambridge, MA 02139 USA

[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA

[5] Molgen AG, Berlin, Germany

[6] Charite Univ Med Berlin, Inst Mol Biol & Bioinformat, Berlin, Germany

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

10.1182/blood.V110.11.5135.5135

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5135

引用

页码：366B / 366B

页数：1

共 50 条

[1] Synergism Between Chemotherapy with 6-Mercaptopurine and DNA Vaccination Against Ph+ Acute Lymphoblastic Leukemia In Syngeneic Mice
Rott, Yvonne
Schmidt, Manuel
Wittig, Burghardt
Herting, Egbert
Kochling, Joachim
BLOOD, 2010, 116 (21) : 1338 - 1338
[2] BCR-ABL specific sequences are required to prevent Ph+ acute lymphoblastic leukemia in syngeneic mice by DNA vaccination.
Koechling, Joachim
Prada, Javier
Bahrami, Masoud
Merediz, Sven A. Koenig
Stripecke, Renata
Seeger, Karl
Henze, Guenter
Wittig, Burghardt
Schmidt, Manuel
BLOOD, 2006, 108 (11) : 931A - 931A
[3] Optimization of DNA vaccine strategies protects mice against syngeneic Ph+ ALL.
Köchling, J
Bahrami, M
Stripecke, R
Wittig, B
Henze, G
Seeger, K
Schmidt, M
BLOOD, 2003, 102 (11) : 746A - 746A
[4] Secondary Ph+ acute lymphoblastic leukemia after temozolomide
Serena De Vita
Silvia De Matteis
Luca Laurenti
Patrizia Chiusolo
Giovanni Reddiconto
Alessia Fiorini
Giuseppe Leone
Simona Sica
Annals of Hematology, 2005, 84 : 760 - 762
[5] Antileukemic Efficacy of Anthocyanins In-Vitro and In-Vivo and In Combination with a DNA Vaccine Against Ph+ Acute Lymphoblastic Leukemia
Rott, Yvonne
Sagner, Michael
Ungefroren, Hendrik
Schmidt, Manuel
Wittig, Burghardt
Herting, Egbert
Kochling, Joachim
BLOOD, 2010, 116 (21) : 1339 - 1339
[6] Prevention of Ph+ acute lymphoblastic leukaemia by DNA vaccination using a non-viral vector system and nanoparticle delivery
Koechling, Joachim
Rott, Yvonne
Arndt, Stefanie
Green, Jordan
Anderson, Daniel
Langer, Robert
Stripecke, Renata
Schmidt, Manuel
Henze, Guenter
Bucsky, Peter
EUROPEAN JOURNAL OF PEDIATRICS, 2008, 167 (03) : 371 - 371
[7] Targeting miR-126 in Ph+ acute lymphoblastic leukemia
Qiao, Junjing
Zhao, Dandan
Nguyen, Le Xuan Truong
Chen, Fang
Liang, Chen
Estrella, Katrina
Ghoda, Lucy Y. Y.
Heisterkamp, Nora
Marcucci, Emanuela C. C.
Kuo, Ya-Huei
Marcucci, Guido
Zhang, Bin
LEUKEMIA, 2023, 37 (07) : 1540 - 1544
[8] Targeting miR-126 in Ph+ acute lymphoblastic leukemia
Junjing Qiao
Dandan Zhao
Le Xuan Truong Nguyen
Fang Chen
Chen Liang
Katrina Estrella
Lucy Y. Ghoda
Nora Heisterkamp
Emanuela C. Marcucci
Ya-Huei Kuo
Guido Marcucci
Bin Zhang
Leukemia, 2023, 37 : 1540 - 1544
[9] Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Webster, Jonathan A.
Luznik, Leo
Tsai, Hua-Ling
Imus, Philip H.
DeZern, Amy E.
Pratz, Keith W.
Levis, Mark J.
Gojo, Ivana
Showel, Margaret M.
Prince, Gabrielle
Bolanos-Meade, Javier
Gondek, Lukasz P.
Ghiaur, Gabriel
Dalton, W. Brian
Jain, Tania
Fuchs, Ephraim J.
Gladstone, Douglas E.
Gocke, Christian B.
Ali, Syed Abbas
Huff, Carol Ann
Borrello, Ivan M.
Swinnen, Lode
Wagner-Johnston, Nina
Ambinder, Richard F.
Jones, Richard J.
Smith, B. Douglas
BLOOD ADVANCES, 2020, 4 (20) : 5078 - 5088
[10] Src kinases in Ph+ lymphoblastic leukemia
Michael Deininger
Nature Genetics, 2004, 36 : 440 - 441

← 1 2 3 4 5 →